Clinical trial NCT03976440 - References

Acute Renal Failure — Simplified Regional Citrate Anticoagulation Protocols for CVVH, CVVHDF and SLED: a Pilot Study

Citation(s)

•   Bagshaw SM, George C, Bellomo R; ANZICS Database Management Committee
  Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care. 2008;12(2):R47. doi: 10.1186/cc6863. Epub 2008 Apr 10.
•   Bai M, Zhou M, He L, Ma F, Li Y, Yu Y, Wang P, Li L, Jing R, Zhao L, Sun S
  Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs. Intensive Care Med. 2015 Dec;41(12):2098-110.
•   Bakker AJ, Boerma EC, Keidel H, Kingma P, van der Voort PH
  Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: use of ionised and total/ionised calcium. Clin Chem Lab Med. 2006;44(8):962-6.
•   Bellomo R, Kellum JA, Ronco C
  Acute kidney injury. Lancet. 2012 Aug 25;380(9843):756-66. doi: 10.1016/S0140-6736(11)61454-2. Epub 2012 May 21. Review.
•   Brophy PD, Somers MJ, Baum MA, Symons JM, McAfee N, Fortenberry JD, Rogers K, Barnett J, Blowey D, Baker C, Bunchman TE, Goldstein SL
  Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). Nephrol Di
•   Buturovic-Ponikvar J, Gubensek J, Ponikvar R
  Citrate anticoagulation for postdilutional online hemodiafiltration with calcium-containing dialysate and infusate: significant clotting in the venous bubble trap. Int J Artif Organs. 2008 Apr;31(4):323-8.
•   Cassina T, Mauri R, Engeler A, Giannini O
  Continuous veno-venous hemofiltration with regional citrate anticoagulation: a four-year single-center experience. Int J Artif Organs. 2008 Nov;31(11):937-43.
•   Chadha V, Garg U, Warady BA, Alon US
  Citrate clearance in children receiving continuous venovenous renal replacement therapy. Pediatr Nephrol. 2002 Oct;17(10):819-24. Epub 2002 Sep 7.
•   Davenport A, Tolwani A
  Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit. NDT Plus. 2009 Dec;2(6):439-47. doi: 10.1093/ndtplus/sfp136. Epub 2009 Sep 25.
•   Demirjian S, Teo BW, Guzman JA, Heyka RJ, Paganini EP, Fissell WH, Schold JD, Schreiber MJ
  Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplant. 201
•   Dorval M, Madore F, Courteau S, Leblanc M
  A novel citrate anticoagulation regimen for continuous venovenous hemodiafiltration. Intensive Care Med. 2003 Jul;29(7):1186-9. Epub 2003 May 22.
•   Fiaccadori E, Maggiore U, Clima B, Melfa L, Rotelli C, Borghetti A
  Incidence, risk factors, and prognosis of gastrointestinal hemorrhage complicating acute renal failure. Kidney Int. 2001 Apr;59(4):1510-9.
•   Fiaccadori E, Maggiore U, Parenti E, Giacosa R, Picetti E, Rotelli C, Tagliavini D, Cabassi A
  Sustained low-efficiency dialysis (SLED) with prostacyclin in critically ill patients with acute renal failure. Nephrol Dial Transplant. 2007 Feb;22(2):529-37.
•   Fiaccadori E, Pistolesi V, Mariano F, Mancini E, Canepari G, Inguaggiato P, Pozzato M, Morabito S
  Regional citrate anticoagulation for renal replacement therapies in patients with acute kidney injury: a position statement of the Work Group "Renal Replace
•   Fiaccadori E, Regolisti G, Cademartiri C, Cabassi A, Picetti E, Barbagallo M, Gherli T, Castellano G, Morabito S, Maggiore U
  Efficacy and safety of a citrate-based protocol for sustained low-efficiency dialysis in AKI using standard dialysis equipment. C
•   Fieghen HE, Friedrich JO, Burns KE, Nisenbaum R, Adhikari NK, Hladunewich MA, Lapinsky SE, Richardson RM, Wald R; University of Toronto Acute Kidney Injury Research Group
  The hemodynamic tolerability and feasibility of sustained low efficiency dialysis i
•   Fliser D, Kielstein JT
  Technology Insight: treatment of renal failure in the intensive care unit with extended dialysis. Nat Clin Pract Nephrol. 2006 Jan;2(1):32-9. Review.
•   Forsythe RM, Wessel CB, Billiar TR, Angus DC, Rosengart MR
  Parenteral calcium for intensive care unit patients. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD006163. doi: 10.1002/14651858.CD006163.pub2. Review.
•   Fukuda T, Toyoshima S, Nakashima Y, Koshitani O, Kawaguchi Y, Momii A
  Tolerable infusion rate of citrate based on clinical signs and the electrocardiogram in conscious dogs. Clin Nutr. 2006 Dec;25(6):984-93. Epub 2006 May 15.
•   Gabutti L, Marone C, Colucci G, Duchini F, Schönholzer C
  Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge. Intensive Care Med. 2002 Oct;28(10):1419-25. Epub 2002 Sep 6.
•   Hetzel GR, Schmitz M, Wissing H, Ries W, Schott G, Heering PJ, Isgro F, Kribben A, Himmele R, Grabensee B, Rump LC
  Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospec
•   Hetzel GR, Taskaya G, Sucker C, Hennersdorf M, Grabensee B, Schmitz M
  Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration. Am J Kidney Dis. 2006 Nov;48(5):806-11.
•   Hoste EA, Clermont G, Kersten A, Venkataraman R, Angus DC, De Bacquer D, Kellum JA
  RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006;10(3):R73. Epub 2006 May 12.
•   Hoste EAJ, Kellum JA, Selby NM, Zarbock A, Palevsky PM, Bagshaw SM, Goldstein SL, Cerdá J, Chawla LS
  Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol. 2018 Oct;14(10):607-625. doi: 10.1038/s41581-018-0052-0. Review.
•   Hsu CY, McCulloch CE, Fan D, Ordoñez JD, Chertow GM, Go AS
  Community-based incidence of acute renal failure. Kidney Int. 2007 Jul;72(2):208-12. Epub 2007 May 16.
•   Kielstein JT, Kretschmer U, Ernst T, Hafer C, Bahr MJ, Haller H, Fliser D
  Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am J Kidney Dis. 2004 Feb;43(2):342-9.
•   Kron J, Kron S, Wenkel R, Schuhmacher HU, Thieme U, Leimbach T, Kern H, Neumayer HH, Slowinski T
  Extended daily on-line high-volume haemodiafiltration in septic multiple organ failure: a well-tolerated and feasible procedure. Nephrol Dial Transplant. 201
•   Liangos O, Wald R, O'Bell JW, Price L, Pereira BJ, Jaber BL
  Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol. 2006 Jan;1(1):43-51. Epub 2005 Oct 26.
•   Mariano F, Bergamo D, Gangemi EN, Hollo' Z, Stella M, Triolo G
  Citrate anticoagulation for continuous renal replacement therapy in critically ill patients: success and limits. Int J Nephrol. 2011;2011:748320. doi: 10.4061/2011/748320. Epub 2011 Mar 16.
•   Mariano F, Morselli M, Bergamo D, Hollo Z, Scella S, Maio M, Tetta C, Dellavalle A, Stella M, Triolo G
  Blood and ultrafiltrate dosage of citrate as a useful and routine tool during continuous venovenous haemodiafiltration in septic shock patients. Nephro
•   Mariano F, Pozzato M, Canepari G, Vitale C, Bermond F, Sacco C, Amore A, Manes M, Navino C; Piedmont and Aosta Valley Section of Italian Society of Nephrology
  Renal replacement therapy in intensive care units: a survey of nephrological practice in northw
•   Mariano F, Tedeschi L, Morselli M, Stella M, Triolo G
  Normal citratemia and metabolic tolerance of citrate anticoagulation for hemodiafiltration in severe septic shock burn patients. Intensive Care Med. 2010 Oct;36(10):1735-43. doi: 10.1007/s00134-010-19
•   Mariano F, Tetta C, Stella M, Biolino P, Miletto A, Triolo G
  Regional citrate anticoagulation in critically ill patients treated with plasma filtration and adsorption. Blood Purif. 2004;22(3):313-9.
•   Mariano F, Triolo G
  [Anticoagulation of extracorporeal circuit in critically ill patients]. G Ital Nefrol. 2007 Jan-Feb;24(1):34-42. Italian.
•   Mariano F
  [Citrate: a different mental approach to extracorporeal circuit anticoagulation]. G Ital Nefrol. 2012 Jan-Feb;29(1):27-32. Italian.
•   Marshall MR, Creamer JM, Foster M, Ma TM, Mann SL, Fiaccadori E, Maggiore U, Richards B, Wilson VL, Williams AB, Rankin AP
  Mortality rate comparison after switching from continuous to prolonged intermittent renal replacement for acute kidney injury in th
•   Marshall MR, Golper TA
  Low-efficiency acute renal replacement therapy: role in acute kidney injury. Semin Dial. 2011 Mar-Apr;24(2):142-8. doi: 10.1111/j.1525-139X.2011.00829.x.
•   Mitchell A, Daul AE, Beiderlinden M, Schäfers RF, Heemann U, Kribben A, Peters J, Philipp T, Wenzel RR
  A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD). Clin Nephrol. 2003 Feb;59(2):106-14.
•   Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P
  Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med. 2004 Feb;30(2):260-265. doi: 10.1007/s00134-003-2047-x. Ep
•   Morabito S, Pistolesi V, Cibelli L, Pierucci A
  [Continuous renal replacement therapies (CRRT) will remain the most widely adopted dialysis modality in the critically ill]. G Ital Nefrol. 2009 Jan-Feb;26(1):13-21. Italian.
•   Morabito S, Pistolesi V, Tritapepe L, Fiaccadori E
  Regional citrate anticoagulation for RRTs in critically ill patients with AKI. Clin J Am Soc Nephrol. 2014 Dec 5;9(12):2173-88. doi: 10.2215/CJN.01280214. Epub 2014 Jul 3. Review.
•   Oudemans-van Straaten HM, Bosman RJ, Koopmans M, van der Voort PH, Wester JP, van der Spoel JI, Dijksman LM, Zandstra DF
  Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med. 2009 Feb;37(2):545-52. doi: 10.1097/CCM.0b013e318195
•   Oudemans-van Straaten HM, Kellum JA, Bellomo R
  Clinical review: anticoagulation for continuous renal replacement therapy--heparin or citrate? Crit Care. 2011 Jan 24;15(1):202. doi: 10.1186/cc9358. Review.
•   Oudemans-van Straaten HM, Wester JPJ, de Pont ACJM, Schetz MRC
  Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based? Intensive Care Med. 2006 Feb;32(2):188-202. doi: 10.1007/s00134-005-0044-y. Epub 2006 Feb
•   Oudemans-van Straaten HM
  Citrate anticoagulation for continuous renal replacement therapy in the critically ill. Blood Purif. 2010;29(2):191-6. doi: 10.1159/000245646. Epub 2010 Jan 8. Review.
•   Palsson R, Niles JL
  Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int. 1999 May;55(5):1991-7.
•   Pistolesi V, Zeppilli L, Polistena F, Sacco MI, Pierucci A, Tritapepe L, Regolisti G, Fiaccadori E, Morabito S
  Preventing Continuous Renal Replacement Therapy-Induced Hypophosphatemia: An Extended Clinical Experience with a Phosphate-Containing Solution
•   Pozzato M
  [Citrate: an additional resource for anticoagulation in continuous replacement therapy]. G Ital Nefrol. 2012 Jan-Feb;29(1):20-6. Italian.
•   Schwenger V, Weigand MA, Hoffmann O, Dikow R, Kihm LP, Seckinger J, Miftari N, Schaier M, Hofer S, Haar C, Nawroth PP, Zeier M, Martin E, Morath C
  Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury - a randomized in
•   Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warnock DG
  Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int. 2001 Jul;60(1):370-4.
•   Tolwani AJ, Wille KM
  Anticoagulation for continuous renal replacement therapy. Semin Dial. 2009 Mar-Apr;22(2):141-5. doi: 10.1111/j.1525-139X.2008.00545.x. Review.
•   VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P
  Intensity of renal
•   Yang Y, Zhang P, Cui Y, Lang X, Yuan J, Jiang H, Lei W, Lv R, Zhu Y, Lai E, Chen J
  Hypophosphatemia during continuous veno-venous hemofiltration is associated with mortality in critically ill patients with acute kidney injury. Crit Care. 2013 Sep 19;17(5

Simplified Regional Citrate Anticoagulation Protocols for CVVH, CVVHDF and SLED Focused on the Prevention of RRT-related Hypophosphatemia and Optimization of Acid-base Balance: a Pilot Study

Details for clinical trial NCT03976440